Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Daron G. Ferris"'
Autor:
Daron G. Ferris, Darron R. Brown, Anna R. Giuliano, Evan Myers, Elmar A. Joura, Suzanne M. Garland, Susanne K. Kjaer, Gonzalo Perez, Alfred Saah, Alain Luxembourg, Christine Velicer
Publikováno v:
Papillomavirus Research, Vol 10, Iss , Pp 100202- (2020)
Objectives: The natural history of human papillomavirus (HPV) infection has been studied extensively in young women; this study investigated HPV infection in adult women. Methods: Data from 3817 women aged 24–45 years in a global trial of the 4-val
Externí odkaz:
https://doaj.org/article/d38ae64d011440be83433bef2fcbfdf3
Autor:
Xavier Castellsagué, Kevin A. Ault, F. Xavier Bosch, Darron Brown, Jack Cuzick, Daron G. Ferris, Elmar A. Joura, Suzanne M. Garland, Anna R Giuliano, Mauricio Hernandez-Avila, Warner Huh, Ole-Erik Iversen, Susanne K. Kjaer, Joaquin Luna, Joseph Monsonego, Nubia Muñoz, Evan Myers, Jorma Paavonen, Punnee Pitisuttihum, Marc Steben, Cosette M. Wheeler, Gonzalo Perez, Alfred Saah, Alain Luxembourg, Heather L Sings, Christine Velicer
Publikováno v:
Papillomavirus Research, Vol 2, Iss , Pp 61-69 (2016)
Background: We estimated the proportion of cervical intraepithelial neoplasia (CIN) cases attributed to 14 HPV types, including quadrivalent (qHPV) (6/11/16/18) and 9-valent (9vHPV) (6/11/16/18/31/33/45/52/58) vaccine types, by region Methods: Women
Externí odkaz:
https://doaj.org/article/4b2ae54684ae46908ab58449bb32e4b5
Publikováno v:
BMC Public Health, Vol 16, Iss 1, Pp 1-7 (2016)
Abstract Background Peru has high cervical cancer incidence and mortality rates compared to other Andean countries. Therefore, partnerships between governmental and international organizations have targeted rural areas of Peru to receive cervical can
Externí odkaz:
https://doaj.org/article/2b4ee47c07c94eeb9a4978df3ac341ba
Autor:
Richard M. Haupt, Eliav Barr, Alfred Saah, Teresa M. Hesley, Scott Vuocolo, Shuang Lu, Roger Maansson, Janine Bryan, Amha Tadesse, Christine Roberts, Frank J. Taddeo, Luisa L. Villa, Evan R. Myers, Nubia Muñoz, Slawomir Majewski, Elmar A. Joura, Joakim Dillner, F. Xavier Bosch, Marc Steben, Matti Lehtinen, Jorma Paavonen, Daron G. Ferris, Grace W.K. Tang, Sven-Eric Olsson, Sepp Leodolter, Suzanne M. Garland, Kevin A. Ault, Patricia García, Eng Hseon Tay, Laura A. Koutsky, Darron R. Brown, Gonzalo Perez, Cosette M. Wheeler, Mauricio Hernandez-Avila, Ole-Erik Iversen, Kristján Sigurdsson, Susanne K. Kjaer
PDF file - 284K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be996bd795a851b1cff6ce8599ad0bb
https://doi.org/10.1158/1940-6207.22523068
https://doi.org/10.1158/1940-6207.22523068
Autor:
Richard M. Haupt, Eliav Barr, Alfred Saah, Teresa M. Hesley, Scott Vuocolo, Shuang Lu, Roger Maansson, Janine Bryan, Amha Tadesse, Christine Roberts, Frank J. Taddeo, Luisa L. Villa, Evan R. Myers, Nubia Muñoz, Slawomir Majewski, Elmar A. Joura, Joakim Dillner, F. Xavier Bosch, Marc Steben, Matti Lehtinen, Jorma Paavonen, Daron G. Ferris, Grace W.K. Tang, Sven-Eric Olsson, Sepp Leodolter, Suzanne M. Garland, Kevin A. Ault, Patricia García, Eng Hseon Tay, Laura A. Koutsky, Darron R. Brown, Gonzalo Perez, Cosette M. Wheeler, Mauricio Hernandez-Avila, Ole-Erik Iversen, Kristján Sigurdsson, Susanne K. Kjaer
Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection from HPV 6/11/16/18–related cervical, vaginal, and vulvar disease through 3 years. We provide an update on the efficacy of the quadrivalent HPV vaccine against hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cbf736043abd5e445fae0fea6dcfd3c
https://doi.org/10.1158/1940-6207.c.6543580
https://doi.org/10.1158/1940-6207.c.6543580
Autor:
Richard M. Haupt, Jorma Paavonen, Nubia Muñoz, Elamin Elbasha, Darron R. Brown, Mauricio Hernandez-Avila, Marc Steben, Daron G. Ferris, Elmar A. Joura, Sepp Leodolter, Suzanne M. Garland, Laura A. Koutsky, Cosette M. Wheeler, Gonzalo Perez, Ralph P. Insinga
Editorial for This Article from Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d417ff86fc590478c93e6f95f6df3255
https://doi.org/10.1158/1055-9965.22435401
https://doi.org/10.1158/1055-9965.22435401
Autor:
Richard M. Haupt, Jorma Paavonen, Nubia Muñoz, Elamin Elbasha, Darron R. Brown, Mauricio Hernandez-Avila, Marc Steben, Daron G. Ferris, Elmar A. Joura, Sepp Leodolter, Suzanne M. Garland, Laura A. Koutsky, Cosette M. Wheeler, Gonzalo Perez, Ralph P. Insinga
Background: We describe transition probabilities for incident human papillomavirus (HPV) 16/18/31/33/35/45/52/58/59 infections and cervical intraepithelial neoplasia (CIN) 1 lesions.Methods: Women ages 16 to 23 years underwent cytology and cervical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::966d204cf1553f03de3a421309c7e53c
https://doi.org/10.1158/1055-9965.c.6514902
https://doi.org/10.1158/1055-9965.c.6514902
Autor:
Richard M. Haupt, Jorma Paavonen, Nubia Muñoz, Elamin Elbasha, Darron R. Brown, Mauricio Hernandez-Avila, Marc Steben, Daron G. Ferris, Elmar A. Joura, Sepp Leodolter, Suzanne M. Garland, Laura A. Koutsky, Cosette M. Wheeler, Gonzalo Perez, Ralph P. Insinga
Table 1A. 12, 24 and 36 month transition probabilities for incident HPV 16, 18, 31, 33, 35, 45, 52, 58 and 59 infections without adjudication of CIN lesions positive for multiple HPV types. Table 1B. 12 and 24 month transition probabilities for incid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d7c1966e4e19e3f86a4db3a36998a24
https://doi.org/10.1158/1055-9965.22435398
https://doi.org/10.1158/1055-9965.22435398
Autor:
Monica M. Matsumoto, John R. Scheel, Erica Pollack, Debra Krotish, Jorge Dunstan, Scott Widemon, José M. García Santos, Geerlitte Farfán, Daniel J. Mollura, Daron G. Ferris, Tatiana Vidaurre
Publikováno v:
Journal of the American College of Radiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ec1ed12137a247047a22f8b14fe58c
https://doi.org/10.1016/j.jacr.2020.06.003
https://doi.org/10.1016/j.jacr.2020.06.003
Autor:
Manual Alvarez, Peng George Wang, Daron G. Ferris, Richard D. Cummings, Wenbo Zhi, Sharad Purohit, Paul Minh Huy Tran, Boying Dun, Lynn Kim Hoang Tran, Diane Hopkins, John J. Wallbillich, David Mysona, Jin-Xiong She
Publikováno v:
Gynecol Oncol
OBJECTIVE: To measure anti-glycan antibodies (AGA) in cervical cancer (CC) patient sera and assess their effect on therapeutic outcome. PATIENTS AND METHODS: Serum AGA was measured in 276 stage II and 292 stage III Peruvian CC patients using a high c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356eee9b3e363a5a5205f88d7694fa2e
https://doi.org/10.1016/j.ygyno.2020.01.014
https://doi.org/10.1016/j.ygyno.2020.01.014